NovoCure NVCR EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from NovoCure’s reported figures.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's EBIT?
- NovoCure (NVCR) reported EBIT of -$67.42M in Q1 2026.
- How has NovoCure's EBIT changed year-over-year?
- NovoCure's EBIT decreased by 78.1% year-over-year, from -$37.87M to -$67.42M.
- What is the long-term trend for NovoCure's EBIT?
- Over 4 years (2021 to 2025), NovoCure's EBIT has grown at a 36.5% compound annual growth rate (CAGR), from -$44.33M to -$153.8M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.